Sotera Health (SHC) Stock
Global sterilization and testing for medical and pharmaceuticals. Here's the price, business snapshot, and what's worth knowing about Sotera Health in August 2026.
Sotera Health Co (SHC) is a global provider of mission‑critical sterilisation, laboratory testing and advisory services for healthcare, medical device and pharmaceutical customers. The business helps clients meet regulatory and safety standards through sterilisation, microbiology and analytical testing, plus validation and consulting. Revenue is influenced by device and pharmaceutical volumes, regulatory inspections and long‑term service contracts; capital expenditure is needed to maintain and expand facilities. Key growth drivers include medical device demand, regulatory tightening and geographic expansion, while risks include contamination or regulatory incidents, pricing pressure, capacity constraints and customer concentration. Market capitalisation is around $4.72bn. This is general educational information only, not personal investment advice. Values can rise or fall, and investors should check current filings, financials and market data before making decisions.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Sotera Health's stock with a target price of $14.75, indicating growth potential.
Financial Health
Sotera Health is showing strong revenue and profits, indicating good financial performance over the past year.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Regulated healthcare demand
Demand links to medical device and pharma growth and tighter regulation, which can support steady service volumes — though performance can vary and incidents may occur.
Global service footprint
A worldwide network helps serve multinational customers and diversify revenue, but adds operational complexity and exposure to regional regulatory differences.
Capital and technology
Investments in facilities and sterilisation technology are necessary for compliance and growth; these are capital‑intensive and can affect margins and cash flow.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
